Q4 2017 Annual Press Conference, and Analysts Call

Our Q4/FY 2017 results have been published on March 8, 2018.

08 Mar 2018

From 07:00 to 15:00

We achieve targets for 2017 – dividend to increase

  • Healthcare and Life Science drive sales growth (+2.0%)
  • EBITDA pre (–1.7%) burdened by currency headwinds
  • Organic sales growth in all regions
  • Progress made in reducing net financial debt
  • Dividend proposal € 1.25 (+€ 0.05)

We are staying the course

“2017 was a good year for our company. We performed well in a challenging environment and met all ourtargets for  the year. We are staying the course and will continue to purposefully implement our innovation-driven growth strategies for Healthcare, Life Science and Performance Materials. In addition, we are resolutely working to quickly lower our acquisition-related debt-to-equity ratio.”

(Stefan Oschmann, CEO and Chairman of the Executive Board)

Related News

View All News

Press Releases

Merck KGaA, Darmstadt, Germany, Achieves Targets for 2017 – Dividend to Increase

Merck KGaA, Darmstadt, Germany met its targets for 2017 and achieved important strategic successes with the approvals of two new medicines.

2018/03/08

Markus Talanow

Financial Communications

Constantin Fest

Head of Investor Relations

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement